Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Test the Safety of the Investigational Drug Selitrectinib in Children and Adults That May Treat Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03215511
Recruitment Status : Active, not recruiting
First Posted : July 12, 2017
Last Update Posted : October 13, 2021
Sponsor:
Information provided by (Responsible Party):
Bayer

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : January 26, 2024
Estimated Study Completion Date : July 26, 2024